Waters Corporation (WAT)
NYSE: WAT · Real-Time Price · USD
345.95
-5.80 (-1.65%)
At close: Oct 28, 2025, 4:00 PM EDT
345.50
-0.45 (-0.13%)
After-hours: Oct 28, 2025, 7:41 PM EDT
Waters Market Cap
Waters has a market cap or net worth of $20.59 billion as of October 28, 2025. Its market cap has decreased by -1.63% in one year.
Market Cap
20.59B
Enterprise Value
21.82B
1-Year Change
-1.63%
Ranking
Category
Stock Price
$345.95
Market Cap Chart
Since December 1, 1998, Waters's market cap has increased from $2.35B to $20.59B, an increase of 776.68%. That is a compound annual growth rate of 8.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 20.94B | -4.95% |
| Dec 31, 2024 | 22.03B | 13.16% |
| Dec 29, 2023 | 19.47B | -4.35% |
| Dec 30, 2022 | 20.35B | -10.51% |
| Dec 31, 2021 | 22.74B | 48.14% |
| Dec 31, 2020 | 15.35B | 1.97% |
| Dec 31, 2019 | 15.06B | 5.36% |
| Dec 31, 2018 | 14.29B | -7.00% |
| Dec 29, 2017 | 15.37B | 41.89% |
| Dec 30, 2016 | 10.83B | -1.47% |
| Dec 31, 2015 | 10.99B | 17.08% |
| Dec 31, 2014 | 9.39B | 10.27% |
| Dec 31, 2013 | 8.51B | 12.38% |
| Dec 31, 2012 | 7.58B | 14.17% |
| Dec 30, 2011 | 6.64B | -6.51% |
| Dec 31, 2010 | 7.10B | 20.97% |
| Dec 31, 2009 | 5.87B | 62.84% |
| Dec 31, 2008 | 3.60B | -54.62% |
| Dec 31, 2007 | 7.94B | 59.78% |
| Dec 29, 2006 | 4.97B | 18.80% |
| Dec 30, 2005 | 4.18B | -26.01% |
| Dec 31, 2004 | 5.65B | 40.43% |
| Dec 31, 2003 | 4.03B | 43.15% |
| Dec 31, 2002 | 2.81B | -44.51% |
| Dec 31, 2001 | 5.07B | -53.04% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |